| Income Statement |
| Operating Expenses | 19.65M |
|
| Research and Development Expense | 320.00K |
| Selling, General and Administrative Expense | 19.20M |
| Operating Income | -19.65M |
| Net Income | -18.27M |
| Net Income Common Stock | -18.27M |
| Net Income Common Stock (USD) | -18.27M |
| Consolidated Income | -18.27M |
| Earnings per Basic Share | -3.68 |
| Earnings per Basic Share (USD) | -3.68 |
| Earnings per Diluted Share | -3.68 |
| Earning Before Interest & Taxes (EBIT) | -18.27M |
| Earning Before Interest & Taxes (USD) | -18.27M |
| Weighted Average Shares | 5.02M |
| Weighted Average Shares Diluted | 5.02M |
| Balance Sheet |
| Cash and Equivalents | 118.29M |
| Cash and Equivalents (USD) | 118.29M |
| Current Assets | 118.55M |
| Total Assets | 118.55M |
| Current Liabilities | 5.24M |
| Total Liabilities | 5.24M |
| Accumulated Retained Earnings (Deficit) | -714.96M |
| Accumulated Other Comprehensive Income | -135.00K |
| Shareholders Equity | 113.31M |
| Shareholders Equity (USD) | 113.31M |
| Trade and Non-Trade Payables | 247.00K |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.43M |
| Net Cash Flow from Investing | 5.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | 5.00M |
| Net Cash Flow from Operations | -3.57M |
| Share Based Compensation | 10.46M |